In vitro cytotoxic effect of difluoromethylornithine increased nonspecifically by peptide coupling

Journal of Pharmaceutical Sciences

Volumn 86, Issue 9, 1997, Pages 997-1000

  Suli Vargha H ^a   Morandini, R ^b   Bodi J ^a   Nagy, L ^a   Medzihradszky Schweiger, H ^a   Ghanem, G ^b  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; EFLORNITHINE DERIVATIVE; MELATONIN RECEPTOR; ORNITHINE DECARBOXYLASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG TARGETING; HUMAN; HUMAN CELL; MELANOMA CELL; POLYAMINE METABOLISM; RECEPTOR BINDING;

EID: 0030765029     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970080d     Document Type: Article

References (28)

1. Metcalf, B. W.; Bey, P.; Danzin, C.; Jung, M. J.; Casara, P.; Vevert, J. P. J. Am. Chem. Soc. 1978, 100, 2551-2553.
2. Kubota, S.; Yamada, T.; Kamei, S.; Seyama, Y. Biochem. Biophys. Res. Comm. 1995, 208, 1106-1115.
3. Awinen, M.; Paasinen, A.; Andersson, L. C.; Höllta, E. Nature 1992, 360, 355-358.
4. Sunkara, P. S.; Prakash, N. J. In Novel Approaches to Cancer Chemotherapy; Sunkara, P. S., Ed.; Academic: New York; 1984; pp 103-126.
5. Gensler, H. L. J. Cancer Res. Clin. Oncol. 1991, 117, 345-350.
6. McCann, P. P.; Pegg, A. E. Pharmacol. Ther. 1992, 54, 195-215.
7. Baurain, R.; Masquelier, M.; Deprez-De Campeneere, D.; Trouet, A. J. Med. Chem. 1980, 23, 1171-1174.
8. Nakanishi, S.; Inoue, A.; Kita, T.; Nakamura, M.; Chang, A. C. Y.; Cohen, S.N.; Numa, S. Nature 1979, 278, 423-427.
9. Eberle, A. N. In The Melanotropins; Karger: Basel, 1988; pp 149-332.
10. The Melanotropic Peptides. Vol. II. Biological Roles; Hadley, M. E., Ed.; CRC: Boca Raton, FL, 1989.
11. Lerner, A. B.; McGuire, J. S. Nature. 1961, 189, 176-179.
12. Ghanem, G.; Comunale, J.; Libert, A.; Vercammen, A.; Lejeune, F. Int. J. Cancer 1988, 41, 248-255.
13. Siegrist, W.; Solca, F.; Stutz. S., Giuffre, L.; Carrel, S.; Girard, J.; Eberle, A. N. Cancer Res. 1989, 49, 6352-6358.
14. Medzihradszky, K. Med. Res. Rev. 1982, 2, 247-270.
15. Sawyer, T. K.; Sanfilippo, C. B.; Hruby, V. J.; Engel, M. H.; Heward, C. B.; Burnett, J. B.; Hadly, M. E. Proc. Natl. Acad. Sci. U.SA. 1980, 77, 5754-5758.
16. Sawyer, T. K.; Hruby, V. J.; Willes, B. D.; Druelos, M. T.; Hadley, M. E.; Bergsneider, M. J. Med. Chem. 1982, 25, 1022-1027.
17. Morandini, R.; Süli-Vargha, H.; Libert, A.; Botyánszki, J.; Medzihradszky, K.; Ghanem, G. Int. J. Cancer 1994, 56, 129-133.
18. Bey, P. H.; Vevert, J.-P.; Van Dorsselaer, V.; Kolb, M. J. Org. Chem. 1979, 44, 2732-2742.
19. Suli-Vargha, H.; Botyánszki, J.; Medzihradszky-Schweiger, H.; Medzihradszky, K. Int. J. Peptide Protein Res. 1990, 36, 308-315.
20. Medzihradszky-Schweiger, H.; Süli-Vargha, H.; Bódi, J.; Medzihradszky, K. Coll. Czech. Chem. Commun. 1988, 53, 2574-2582.
21. Schwyzer, R.; Costopanagiotis, A., Sieber, P. Helv. Chim. Acta 1963, 46, 870-889.
22. Arnould, R.; Dubois, J.; Abikhalil, F.; Libert, A.; Ghanem, G.; Atassi, G., Hanocq, M.; Lejeune, F. J. Anticancer Res. 1990, 10, 145-154.
23. 6; Karpela, T.; Christen, P., Eds.; Birkhäuser Verlag: Basel, 1987; pp 333-336.
24. Poulin, R.; Lu, L.; Ackermann, B.; Bey, Ph.; Pegg, A. E. J. Biol. Chem. 1992, 267, 150-158.
25. Swope, V. B.; Medrano, E. E.; Smalara, D.; Abdel-Malek, Z. A. Exp. Cell. Res. 1995, 217, 453-459.
26. Casero, R. A.; Go, B.; Theiss, H. W.; Smith, J.; Baylin, S. B.; Luk, G. D. Cancer Res. 1987, 47, 3964-3967.
27. Sunkara, P. S.; Chang, C. C., Prakash, N. J., Lachmann, P. J. Cancer Res. 1985, 45, 4067-4070.
28. Jeney, A.; Kopper, L.; Nagy, P.; Lapis, K.; Süli-Vargha, H.; Medzihradszky, K. Cancer Chemother. Pharmacol. 1986, 16, 129-132.